Biomarkers of environmental enteric dysfunction are differently associated with recovery and growth among children with moderate acute malnutrition in Sierra Leone.
Sierra Leone
biomarkers
environmental enteric dysfunction
fecal host mRNA transcripts
fecal host proteins
growth outcomes
intestinal antimicrobial defense
intestinal inflammation
intestinal permeability
lactulose: mannitol test
Journal
The American journal of clinical nutrition
ISSN: 1938-3207
Titre abrégé: Am J Clin Nutr
Pays: United States
ID NLM: 0376027
Informations de publication
Date de publication:
01 06 2021
01 06 2021
Historique:
received:
30
05
2020
accepted:
16
12
2020
pubmed:
6
3
2021
medline:
29
6
2021
entrez:
5
3
2021
Statut:
ppublish
Résumé
Environmental enteric dysfunction (EED) may influence growth during and recovery from moderate acute malnutrition (MAM), however, biomarkers to assess these relations have yet to be identified. The objectives of this study were to: 1) develop a score for EED based on host fecal mRNA transcripts, 2) compare biomarkers of EED with each other, and 3) examine associations between the EED biomarkers and recovery from MAM and growth outcomes. In a cohort of 520 Sierra Leonean MAM children, biomarkers of EED included the lactulose: mannitol (L: M) test, 15 host fecal mRNA transcripts, and host fecal proteins [α-1-antitrypsin (AAT), myeloperoxidase (MPO), neopterin (NEO)]. Anthropometry data were also collected and z scores were computed for length-for-age (LAZ) and weight-for-length (WLZ). Recovery from MAM was defined as midupper arm circumference ≥12.5 cm. Factor analysis was used to identify EED scores using the mRNA transcripts, and mixed effects regression was conducted to test for associations. The 15 host fecal mRNA transcripts were clustered into 3 scores: gut inflammation (GI) score, gut structure (GS) score, and gut defense (GD) score. We found agreement between certain inflammation markers (GI score and MPO), and permeability markers (GS score and AAT; AAT and the L: M excretion ratio). Antimicrobial gut defense (GD score) was inversely associated with percent lactulose excreted, a measure of intestinal permeability. LAZ (β: -0.08; 95% CI: -0.14, -0.02) and WLZ (β: -0.03; 95% CI: -0.06, -0.01) were negatively associated with GI score. A high GD score (β: 0.36; 95% CI: 0.08, 0.64) and low AAT (β: -1.35; 95% CI: -2.35, -0.36) were associated with recovery from MAM. Scores derived from host fecal mRNA transcript variably correlated with the L: M test and host fecal proteins. Markers of intestinal inflammation, permeability, and defense were associated with growth outcomes and recovery from MAM.
Sections du résumé
BACKGROUND
Environmental enteric dysfunction (EED) may influence growth during and recovery from moderate acute malnutrition (MAM), however, biomarkers to assess these relations have yet to be identified.
OBJECTIVES
The objectives of this study were to: 1) develop a score for EED based on host fecal mRNA transcripts, 2) compare biomarkers of EED with each other, and 3) examine associations between the EED biomarkers and recovery from MAM and growth outcomes.
METHODS
In a cohort of 520 Sierra Leonean MAM children, biomarkers of EED included the lactulose: mannitol (L: M) test, 15 host fecal mRNA transcripts, and host fecal proteins [α-1-antitrypsin (AAT), myeloperoxidase (MPO), neopterin (NEO)]. Anthropometry data were also collected and z scores were computed for length-for-age (LAZ) and weight-for-length (WLZ). Recovery from MAM was defined as midupper arm circumference ≥12.5 cm. Factor analysis was used to identify EED scores using the mRNA transcripts, and mixed effects regression was conducted to test for associations.
RESULTS
The 15 host fecal mRNA transcripts were clustered into 3 scores: gut inflammation (GI) score, gut structure (GS) score, and gut defense (GD) score. We found agreement between certain inflammation markers (GI score and MPO), and permeability markers (GS score and AAT; AAT and the L: M excretion ratio). Antimicrobial gut defense (GD score) was inversely associated with percent lactulose excreted, a measure of intestinal permeability. LAZ (β: -0.08; 95% CI: -0.14, -0.02) and WLZ (β: -0.03; 95% CI: -0.06, -0.01) were negatively associated with GI score. A high GD score (β: 0.36; 95% CI: 0.08, 0.64) and low AAT (β: -1.35; 95% CI: -2.35, -0.36) were associated with recovery from MAM.
CONCLUSIONS
Scores derived from host fecal mRNA transcript variably correlated with the L: M test and host fecal proteins. Markers of intestinal inflammation, permeability, and defense were associated with growth outcomes and recovery from MAM.
Identifiants
pubmed: 33668048
pii: S0002-9165(22)00733-X
doi: 10.1093/ajcn/nqaa434
pmc: PMC8243924
doi:
Substances chimiques
Biomarkers
0
RNA, Messenger
0
Types de publication
Journal Article
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
1556-1564Informations de copyright
© The Author(s) 2021. Published by Oxford University Press on behalf of the American Society for Nutrition.
Références
Arch Immunol Ther Exp (Warsz). 2000;48(4):251-8
pubmed: 11059641
Mol Immunol. 2003 Nov;40(7):469-75
pubmed: 14568394
BMC Public Health. 2013;13 Suppl 3:S23
pubmed: 24564235
Am J Clin Nutr. 2017 Jul;106(1):245-255
pubmed: 28592604
Clin Infect Dis. 2014 Nov 1;59 Suppl 4:S213-9
pubmed: 25305289
Clin Infect Dis. 2014 Nov 1;59 Suppl 4:S207-12
pubmed: 25305288
Br Med J. 1977 Feb 12;1(6058):428-9
pubmed: 300037
Proc Natl Acad Sci U S A. 2003 Aug 5;100(16):9440-5
pubmed: 12883005
Kurume Med J. 1998;45(1):69-73
pubmed: 9658754
J Pediatr Gastroenterol Nutr. 2017 Jul;65(1):31-39
pubmed: 28644347
Cell Mol Gastroenterol Hepatol. 2015 Dec 11;2(2):158-174.e1
pubmed: 26973864
Pediatr Res. 2003 Sep;54(3):306-11
pubmed: 12788978
Lancet. 1991 Oct 12;338(8772):907-10
pubmed: 1681266
BMC Med. 2019 Nov 25;17(1):181
pubmed: 31760941
PLoS One. 2013 May 29;8(5):e64636
pubmed: 23734210
Exp Biol Med (Maywood). 2018 Aug;243(12):985-989
pubmed: 30099958
Cell Immunol. 2016 May;303:43-9
pubmed: 27063479
PLoS Negl Trop Dis. 2018 Jan 19;12(1):e0006205
pubmed: 29351288
Clin Infect Dis. 2015 Dec 15;61 Suppl 7:S726-32
pubmed: 26602300
PLoS One. 2018 Mar 2;13(3):e0192092
pubmed: 29499047
BMC Med. 2014 Oct 14;12:187
pubmed: 25604120
Am J Trop Med Hyg. 2016 Sep 7;95(3):694-701
pubmed: 27352872
Am J Trop Med Hyg. 2013 Feb;88(2):390-396
pubmed: 23185075
Behav Res Methods. 2007 May;39(2):175-91
pubmed: 17695343
Pediatr Res. 1998 Oct;44(4):519-23
pubmed: 9773840
J Pediatr Gastroenterol Nutr. 2017 Jul;65(1):40-46
pubmed: 28644348
J Pediatr Gastroenterol Nutr. 2016 Nov;63(5):453-459
pubmed: 27347722